Skip to main content
PharmSpace

Class Explorer · Hematology

Hematinics

Replacement of the substrates of erythropoiesis. Each one corrects a different deficiency, and giving the wrong one is a way to delay the diagnosis.

Members

Also in this class: Ferrous fumarate · Ferric gluconate · Iron sucrose (IV). Full pages arrive as the library grows.

Compare the members

Ferrous sulfate
Corrects
Microcytic, iron deficiency
Note
Alternate-day dosing absorbs better
Cyanocobalamin (vitamin B12)
Corrects
Macrocytic, B12 deficiency
Note
Check before giving folate
Folic acid
Corrects
Macrocytic, folate deficiency
Note
Never before excluding B12 deficiency

Shared across the class

Indications
Nutritional anemias · Deficiency states
Adverse effects
Gastrointestinal upset (iron) · Injection-site reactions
Contraindications
Iron overload states · Undiagnosed anemia, where treating first buries the cause
Monitoring
Reticulocyte rise at about one week as proof of response · Hemoglobin and mean cell volume at four to eight weeks · Ferritin to confirm stores are replete before stopping iron

What makes each agent different

  • Iron corrects a microcytic anemia; B12 and folate correct a macrocytic one. The mean cell volume is the first branch point and it is cheap.
  • Giving folate to a B12-deficient patient corrects the blood count while the neurological damage continues. That is the single most important sequencing rule in this class.

Alternate-day iron dosing produces better absorption than daily dosing, because a dose raises hepcidin for about 24 hours and blocks the next one.

Iron deficiency in an adult male or a postmenopausal female is a gastrointestinal investigation until proven otherwise; the tablet is the easy half of the response.

Last reviewed 2026-08-16 · Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed.